Shao Wei-Li sold $222K of OMDA
Shao Wei-Li (President) sold 8,866 shares of Omada Health, Inc. (OMDA) at $25.02 ($0.22M total) on 2026-08-12 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The President’s open-market sale under a 10b5-1 plan is typically interpreted as pre-planned liquidity rather than a directional fundamental signal.
Market read
Traders may treat this as low-signal, but it can be used to contextualize OMDA insider activity.
What to watch
The article does not state whether other insiders sold, whether there were concurrent option exercises, or whether the sale size is unusual versus prior patterns.
Background
The article is a SEC Form 4 insider transaction disclosure for Omada Health, Inc.
Ticker impact
Omada Health insider Shao Wei-Li sold 8,866 shares on 2026-08-12 at $25.0167, totaling about $221.8K under a 10b5-1 plan.
Likely minimal, with any impact confined to short-term sentiment rather than fundamentals.
The filing is a Form 4 insider sale explicitly tied to a pre-arranged 10b5-1 plan, and the article contains no accompanying operational or financial catalyst.
Market effects
No direct sector read-through; this is company-specific insider trading with no stated business change.
None indicated.
None indicated.
Counterpoint
Insider sales can sometimes precede negative developments, so traders may watch for follow-on disclosures even if the sale is 10b5-1.
Key entities
- issuerOmada Health, Inc.
Company whose insider transaction is disclosed on Form 4.
- insiderShao Wei-Li
President of Omada Health who sold shares under a 10b5-1 plan.
